Vernalis PLC Share News (VER)

Vernalis Takes Steps To Drive Demand For Tuzistra, Progress Pipeline

UK Shareholder Meetings Calendar - Next 7 Days

BROKER RATINGS SUMMARY: Investec Starts Wolseley With Hold Rating

Vernalis shares down on disappointing full year

(ShareCast News) - Vernalis posted its audited results for the year to 30 June on Thursday, with revenue dropping to £12.03m from £13.71m in the year to 30 June 2015. The AIM-traded firm reported an operating loss before exceptional items of £26.22m, widening significantly from £8.22m in the prior y

Vernalis Reaches Milestone In French Oncology Collaboration

Vernalis Notes Juno Therapeutics To Buy Partner RedoxTherapies

Vernalis Completes Study On CCP-08 Cough And Cold Product

Vernalis Annual Trading In Line With Expectations

DIRECTOR DEALINGS: Vernalis CEO And CFO Buy Shares

BROKER RATINGS SUMMARY: Numis Upgrades Close Brothers To Buy

LONDON BRIEFING: Ladrokes Rises As Gala Coral Merger Nears Approval

Moxatag supply issues looming for Vernalis

(ShareCast News) - Vernalis warned investors on Thursday of looming supply issues with an upcoming drug it will distribute - Moxatag - as its Ireland-based supplier Suir Pharma was placed into provisional liquidation. The AIM-traded company said information was limited at this time, but it had been

Vernalis Says Supplier Of Moxatag Placed In Provisional Liquidation

DIRECTOR DEALINGS SUMMARY: Vernalis Raises GBP40 Million

Vernalis raises £40m in placing

(ShareCast News) - Specialty pharmaceutical company Vernalis announced a £40m placing on Tuesday, through the issue of 80 million new ordinary shares at a price of 50p apiece. The AIM-traded firm said the placing shares have been conditionally placed by the joint bookrunners with institutional inves